rs12946942 — SOX9

Intergenic variant in the SOX9 upstream regulatory region on chromosome 17q24.3 associated with increased susceptibility to severe adolescent idiopathic scoliosis (AIS) across multiple ethnic populations

See your personal result for SOX9

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

SOX9 rs12946942 — Skeletal Blueprint Variant and Scoliosis Risk

Your spine's shape is determined early in skeletal development by a cascade of transcription factors that instruct cartilage and bone formation with extraordinary precision. SOX911 SOX9
SRY-box transcription factor 9 — a master regulator of chondrogenesis (cartilage-forming cell differentiation) and skeletal patterning sits at the top of this cascade, controlling when and where cartilage cells form, proliferate, and mature into the structural templates that become bone. When SOX9 dosage is disrupted — whether by mutations in the coding sequence or by altered expression from its upstream regulatory region — the skeletal consequences can be severe, including conditions that cause the spine to curve abnormally. The rs12946942 T allele, located in the expansive regulatory landscape roughly 880 kilobases upstream of SOX9 on chromosome 17q24.3, is the most robustly replicated common genetic risk variant for severe adolescent idiopathic scoliosis (AIS)22 adolescent idiopathic scoliosis (AIS)
A lateral curvature of the spine (Cobb angle ≥10°) that appears during adolescence with no identified underlying cause — "idiopathic" means its origin is unknown. AIS affects 2–3% of adolescents, with severe cases (Cobb angle ≥40°) often requiring surgical correction.

The Mechanism

SOX9 at 17q24.3 is embedded in a vast regulatory landscape: the topologically associating domain (TAD)33 topologically associating domain (TAD)
A genomic neighborhood where enhancers and their target gene(s) are corralled together by three-dimensional chromatin folding, ensuring regulatory elements act on the right gene even when separated by hundreds of kilobases surrounding SOX9 extends hundreds of kilobases upstream and contains numerous enhancers that drive tissue- and stage-specific SOX9 expression. Deletions within this upstream regulatory zone — some reaching megabases in size — cause campomelic dysplasia, a severe skeletal malformation syndrome, by reducing SOX9 expression even though the SOX9 coding sequence itself is intact. This "position effect" principle establishes that the chromosome 17q24.3 region surrounding rs12946942 is functionally critical for correct SOX9 dosage in developing skeletal tissues.

The rs12946942 G>T substitution sits in the intergenic zone between KCNJ2 (ending ~70.2 Mb) and SOX9 (starting ~72.1 Mb). While the precise functional consequence of this T allele is not yet characterized at the molecular level, in silico analyses44 in silico analyses
Computational analyses of chromatin accessibility, transcription factor binding site predictions, and expression quantitative trait locus (eQTL) datasets applied to the 17q24.3 locus in the landmark Takeda 2019 multiethnic study identified SOX9 as the most likely susceptibility gene at this locus. The T allele may alter a transcription factor binding site within an SOX9 enhancer active during vertebral column and intervertebral disc development, subtly reducing SOX9 expression in the precise spinal tissues where proper chondrocyte patterning prevents curve initiation and progression.

The Evidence

The association between rs12946942-T and severe AIS was first identified by Miyake et al. 201355 Miyake et al. 2013
Two-stage GWAS and replication in Japanese and Chinese cohorts, total ~12,000 subjects, focusing on AIS cases with Cobb angle ≥40° requiring surgery reaching genome-wide significance (OR=2.05 under a recessive model, P=4.00×10⁻⁸) and strengthening with replication (combined OR=2.21, P=6.43×10⁻¹²). The finding was validated in a multiethnic meta-analysis66 multiethnic meta-analysis
Takeda et al. 2019 — four ethnically diverse cohorts from Japan, Sweden, Finland, Hong Kong, and China; 2,272 severe AIS cases and 13,859 controls confirming the T allele with OR=1.36 (95% CI 1.25–1.49, P=7.23×10⁻¹³) under an additive model. The effect size is robust across Japanese, Chinese, Swedish, and Finnish cohorts — a true multiethnic signal rather than a population-specific association.

Notably, rs12946942 associates specifically with severe AIS (Cobb angle typically ≥40°, requiring surgical consideration), not with mild AIS or general spinal curvature. The recessive signal seen in the original Japanese GWAS (OR=2.05 for T/T homozygotes) suggests the double-dose of the T allele has a particularly strong effect on the severe end of the curve spectrum. In contrast, a 2025 study (Dai et al.77 Dai et al.
319 AIS cases evaluated for brace treatment outcomes) found no significant association between rs12946942 and brace treatment success or failure — suggesting this locus governs initial skeletal susceptibility and progression severity rather than the biomechanical response to bracing.

The T allele frequency shows striking population stratification: ~7.5% in Europeans vs ~23% in East Asians (Korean data reaches 27–28%). This parallels the higher clinical prevalence of severe AIS in East Asian adolescents documented in epidemiological studies.

Practical Actions

For T allele carriers, the primary implication is an elevated biological predisposition for spinal curves to initiate and progress during adolescence. This does not mean scoliosis is inevitable — AIS is a complex trait influenced by many genetic and environmental factors — but T carriers, particularly TT homozygotes, have a meaningfully higher prior probability of developing curves that progress to clinically significant severity. Early clinical detection through forward-bend testing (Adam's forward bend test), followed by radiographic measurement if warranted, is the cornerstone of management.

For adolescents identified with early AIS who carry the T allele, close radiographic monitoring during peak growth velocity (typically ages 11–14 for girls, 13–16 for boys) is especially important, as this is the window of highest progression risk. The SOX9 locus association with curve severity (not merely curve presence) means that T allele carriers who already have any detected curve warrant more aggressive monitoring intervals than the genetic background alone would predict.

Interactions

SOX9 does not act alone in spinal development — it works within a network of transcription factors and signaling pathways. The LBX1 locus variant rs1119087088 rs11190870
The strongest overall AIS GWAS signal, near LBX1 (ladybird homeobox 1) on chromosome 2p16 — associated with general AIS susceptibility in multiple populations at P values exceeding 10⁻¹⁸ is a well-replicated independent AIS risk locus. Carrying risk alleles at both SOX9 (rs12946942) and LBX1 (rs11190870) may confer additive risk for curve initiation and severe progression, though no published study has formally analyzed the combined genotype effect. KCNJ2, the other gene bracketing this intergenic locus, encodes an inward-rectifier potassium channel implicated in skeletal muscle function and cardiac rhythm; gain-of-function KCNJ2 mutations cause Andersen-Tawil syndrome with periodic paralysis and skeletal abnormalities. Whether the AIS risk at rs12946942 involves KCNJ2 expression, SOX9 regulatory effects, or a locus-level mechanism that perturbs both remains an active research question.

Genotype Interpretations

What each possible genotype means for this variant.

GG Normal

Common genotype — standard skeletal developmental programming at the SOX9 locus

You carry two copies of the G allele, the reference form of this variant found in approximately 84% of people globally. Your SOX9 upstream regulatory region at this position does not carry the variant associated with elevated risk of severe adolescent idiopathic scoliosis. Your baseline risk for curve development and progression follows population norms.

GT Intermediate

One risk copy — modestly elevated predisposition to severe AIS progression

The chromosome 17q24.3 locus where rs12946942 sits is part of a large regulatory zone that governs SOX9 expression in skeletal tissues. SOX9 is the master transcription factor for chondrogenesis — it controls the timing and pattern of cartilage cell differentiation that shapes the vertebral column during growth. Even a subtle change in SOX9 dosage at a critical developmental window may alter the biomechanical properties of the growing spine in a way that permits curve initiation and propagation under normal gravitational loads.

The heterozygous GT genotype carries an intermediate risk between the common GG and the higher-risk TT. The effect is most relevant during the adolescent growth spurt (approximately ages 10–16), when the spine is elongating rapidly and any pre-existing tendency for asymmetric growth is most likely to manifest as measurable curvature.

TT High Risk

Two risk copies — substantially elevated predisposition to severe adolescent scoliosis

With both copies of the T allele, the putative alteration in SOX9 upstream regulatory activity is present on both chromosomes. SOX9 encodes a transcription factor with gene dosage sensitivity | Haploinsufficiency for SOX9 (one functional copy) causes campomelic dysplasia, a severe skeletal dysplasia — demonstrating that the amount of SOX9 protein produced matters critically for normal skeletal development: even modest reductions in SOX9 expression during critical windows of vertebral column patterning can alter chondrocyte behavior in a way that predisposes to asymmetric growth and curve formation.

The TT genotype's OR of ~2.21 under a recessive model means the elevated risk concentrates specifically in homozygotes — a pattern consistent with a variant that disrupts a regulatory binding site where two altered copies are needed to appreciably reduce SOX9 expression below a developmental threshold. The association is specifically with severe AIS (curves generally ≥40° Cobb angle, requiring surgical consideration), not with all forms of spinal curvature. This distinction is clinically meaningful: TT carriers who develop any detectable AIS curve are at higher-than-average risk of progressing to surgical severity if growth-phase management is suboptimal.

The T allele frequency is substantially higher in East Asian populations (~23% in Japanese and Chinese cohorts vs ~8% globally), making TT homozygosity roughly 5-fold more common in East Asian individuals — a finding that is epidemiologically consistent with the higher severe AIS prevalence documented in East Asian adolescents.